The acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with nephropathy in Chinese patients with type 2 diabetes

Sydney Tang(University of Hong Kong), V. T. M. Leung, Loretta Y.Y. Chan(Queen Mary Hospital), Sharon Wong(United Christian Hospital), D. W. S. Chu, Joseph C.K. Leung(University of Hong Kong), Y. W. Ho(Queen Mary Hospital), Kar Neng Lai(University of Hong Kong), Lijun Ma, Steven C. Elbein, D. W. Bowden(Wake Forest University), Andrew A. Hicks, Mary E. Comeau(Biostatistical Consulting (United States)), Carl D. Langefeld(Biostatistical Consulting (United States)), Barry I. Freedman
Nephrology Dialysis Transplantation
June 2, 2010
Cited by 47Open Access
Full Text

Abstract

BACKGROUND: A single-nucleotide polymorphism (SNP), rs2268388, in the acetyl-coenzyme A carboxylase beta (ACACB) gene is associated with susceptibility to type 2 diabetic nephropathy (T2DN) in Japanese and European-American populations. Whether this association also exists in Chinese patients is unclear. Attempts at replication in small Singaporean and Korean samples were not significant. METHODS: Eight ACACB SNPs were genotyped in 595 subjects with type 2 diabetes mellitus born in Hong Kong or southern China, 295 with advanced T2DN and 300 with long-standing diabetes lacking nephropathy. Association analyses were focused primarily on SNP rs2268388 and secondarily on flanking SNPs and haplotypes. RESULTS: Adjusting for age, gender and diabetes duration, ACACB SNP rs2268388 was significantly associated with advanced T2DN (odds ratio = 2.39; recessive model; P = 0.0129). CONCLUSION: These results in the Chinese replicate the association between T2DN and rs2268388, as seen in Japanese and European Americans. The ACACB gene and attendant alterations in fatty acid oxidation may play important roles in susceptibility to T2DN. Targeting this pathway may provide novel treatment options for the prevention of diabetic nephropathy.


Related Papers

No related papers found

Powered by citation graph analysis